학술논문

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study
Document Type
Article
Source
In: npj Breast Cancer. (npj Breast Cancer, December 2021, 7(1))
Subject
Language
English
ISSN
23744677